PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Pricing and Market Access
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Connecting healthcare tech with the life sciences industry
Optimizing Cell & Gene Therapy Processes
Collaboration and Expertise in Contract Analytical Chemistry
A new generation of CDMO services
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
The next chapter of clinical trial services
Putting quality first in the pharma supply chain
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions
What is the pharmacy of the future?
Preparing for DSCSA transition with tech-led compliance
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Pricing and Market Access
Latest
Matinas BioPharma mulls wind-down as antifungal therapy deal falls through
Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions
Roche to leverage Dyno Therapeutics tech for novel gene therapies in neuro disorders
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Foreign Direct Investment
Latest
Reeves’ 2024 budget promises life sciences investment
Bladder cancer diagnoses to top 300,000 in major markets by 2033
EC approves AstraZeneca’s Fasenra for EGPA treatment
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Gilead Sciences reports net income rise in Q2 2024
Amgen reports 45.9% decline in net income to $746m in Q2 2024
Q2 2024 update: electronic medical record (emr) systems related private equity activity in the pharmaceutical industry
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Transforming pharmaceutical R&D: the impact of digital technologies on drug discovery and development
Futureproofing supply chains in an evolving pharmaceutical industry
Transforming CML patient monitoring with ICON’s innovative RNA-based NGS assay
Events
Buy Reports
Newsletters
PT
All articles by
Rankings
Companies Rankings
How to Enter
Categories
Winners
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
View more
